When fungicide efficacy declines due to the development of resistance in the pathogen population, growers have to either change to an alternative mode of action or adjust their treatment programme. Adjustments may include either decreasing (or stopping) use of the mode of action, or increasing the total dose applied (by increasing number of applications and/or dose per application, where permitted) to try to maintain effective disease control. This study explores the circumstances under which increasing/decreasing total applied fungicide is financially optimal. A model based on field data is used to optimize the dose of fungicide applied when fungicide resistance develops in a pathogen population. The model is used to explore contrasting pathosystems and fungicide classes. When qualitative fungicide resistance develops, the shape of the disease-yield loss relationship determines whether the optimal total dose increases or decreases with increasing frequency of resistance in the pathogen population. When quantitative fungicide resistance develops, such that effective control can still be obtained with doses close to the maximum permitted dose, the optimal dose increases with increasing frequency of resistance in the pathogen population.
Introduction
Fungicides are a cost-effective means of plant pathogen control in many crops (Hardwick et al., 2001; Pemsl & Waibel, 2007; Wiik & Rosenqvist, 2009; Lopez et al., 2015) . Positive net monetary returns of fungicide usage have been reported by several authors (Hardwick et al., 2001; Wiik & Rosenqvist, 2009; Lopez et al., 2015) . Fungicide use also puts a selection pressure to develop resistance against the fungicide on the pathogen populations they control. The word 'resistance' is used here to cover both qualitative resistance (also termed disruptive or single-step resistance; www.frac.info/resistance-overvie w), where a new pathogen strain is insensitive to the maximum field dose of fungicide, and quantitative resistance (multistep or shifting type resistance), where new pathogen strains remain sensitive to a certain degree. Previously, three phases of fungicide resistance development have been defined (van den Bosch et al., 2011) : (i) an emergence phase during which new resistant strains occur by mutation and invade the population; (ii) a selection phase, during which the frequency of resistant strains increases; and (iii) an adjustment phase, when the frequency of resistance affects field efficacy and growers have to change their fungicide treatments. If an effective alternative mode of action (MOA) is available, the adjustment may be simply to switch to alternative fungicides. In the absence of an alternative, growers have to decide how to adjust either the number of fungicide applications or the dose per application. It is now common practice in many countries for fungicides to be used on some crops at a dose lower than the maximum permitted dose (Jørgensen et al., 2017) , so an increase or decrease in dose are both practical options. The analysis reported here considers only the adjustment phase, but it is appreciated that in many cases the selection and adjustment phases overlap. The discussion considers possible conflicts between adjusting to maximize net return from a crop and the longer term aim to reduce selection. This paper considers the effect of the build-up of resistance on the cost due to disease (defined here as the sum of the cost of the yield lost to disease and the cost of applying a fungicide to reduce that loss), and shows how the optimal treatment programme is affected by the build-up of resistance. The cost of fungicide increases linearly with total dose (number of applications per crop and dose per application), whereas the cost of yield loss decreases nonlinearly with increasing total dose. Hence, there is a financially optimum dose at which cost due to disease is minimized. The key question to consider is whether the optimal treatment dose increases or decreases when resistance to the fungicide is building up. In an extreme case, if an entire pathogen population became qualitatively resistant, efficacy would be zero and the optimum dose for the pathogen under consideration will also be zero. Growers are unlikely to use fungicides that have lost all efficacy (unless they provide other growth regulatory or physiological benefits; Wu & von Tiedemann, 2001) . But if resistance is quantitative (because the mutations have only a limited effect on sensitivity) growers may be inclined to increase fungicide inputs in an attempt to maintain control, or may decide to reduce inputs when they feel the benefit of the applications is reduced significantly. For example, data from long-term field experiments show that the declines in field performance of QoI and triazole fungicide have been expressed through contrasting changes to their respective dose-response curves (Blake et al., 2017) . Pesticide usage survey data from the UK (https://secure.fera.defra.gov. uk/pusstats/) show that QoI (FRAC class 11) usage on wheat fell sharply after resistance in Zymoseptoria tritici became widespread. In contrast, triazole usage has increased with the development of resistant strains. To test whether this makes sense from a net return viewpoint, one needs to know how the financially optimum dose changes as the fraction of resistance changes, and whether the characteristics of the pathosystem change the shape of the relationship. Previously (te Beest et al., 2013), a method was developed to calculate the financially optimal dose of a fungicide application programme. The present study builds on this approach by including the development of resistance to the fungicide.
Although net returns of fungicide use are on average positive, they show large variability. For southern Sweden, for example, Wiik & Rosenqvist (2009) calculated that in 10 out of 24 years the net return of fungicide treatment programmes used by growers was zero or even negative. The year-to-year variability in disease pressure is one of the main causes of this variability in return (Wiik & Rosenqvist, 2009; te Beest et al., 2013; Lopez et al., 2015) . A given treatment programme may give a considerable positive net return in a year with an average disease pressure, but may have a negative return in low disease years because the costs of the treatment programme are larger than the yield gain that disease control will bring. In high disease years, yield loss may be large, making the crop unprofitable despite the fungicide programme giving a positive net financial return. Growers then suffer considerable losses, which in extreme cases may result in failure of the business. Growers may very well be willing to use higher dosages as 'insurance' against these infrequent years where a high disease severity will develop that potentially causes a critical financial loss. This is termed 'risk aversion' and has been discussed by various authors. te Beest et al. (2013) were the first to introduce a method to include risk aversion in the calculation of financially optimal dosages. They found that the optimal dosage when accounting for risk aversion is much higher, and closer to what is used in practice by growers, than the optimal long-term average dose.
Both the long-term average optimal dose and the optimal dose accounting for risk aversion are considered here, and it is shown how optimal treatment dose varies with the development of fungicide resistance in the pathogen population.
Materials and methods
The cost-benefit analysis
Disease variability
To capture the year to year variability in disease pressure, a probability density function, P(S), is introduced, that is interpreted as the probability that in a growing season an epidemic develops that reaches severity S if no fungicides are applied. The probability density function needs to be able to take a wide range of shapes so that it can be used to describe contrasting diseases of interest.
The severity, S, is defined as the fraction of the host surface with disease symptoms, and can vary between 0 and 1. The beta distribution is used to model P(S). This distribution is very flexible and can describe a wide range of shapes. The distribution is given by:
where B (a,b) is the beta-function Bða; bÞ
and a and b are parameters shaping the beta distribution.
Calculation of cost due to disease
The calculation of the total cost due to the fungicide application and due to the disease-induced yield loss is explained. The resulting equation forms the basis of all further calculations.
Assumption. It is assumed that yield is well correlated with the severity of the epidemic at a key growth stage of the crop. This is an appropriate simplification of reality in many cases. For example, the grain yield of wheat lost due to the pathogen Z. tritici is known to be correlated to disease severity at growth stage 75 (Zadoks et al., 1974) . Datasets of severity variation across large numbers of sites and seasons (needed for the analysis of variability and risk) are usually from single time point observations and the model was built to work with this type of data. The same reasoning holds for grapevine diseases because grape quality at the time of harvest is a critical determinant of product value. The disease severity S, in the probability density function, P(S), is hereonin interpreted as the disease severity at this key growth stage.
Definition. The total cost due to disease (of fungicide applications and yield loss due to the disease) is denoted by C(S, A). A is the fungicide application programme. See Box 1 for an explanation about the notation on treatment programmes.
Cost calculation. The cost of the fungicide application, C F (A), includes the cost of the fungicide i, C Ai , and the fixed cost of spraying the fungicide in the field (labour, tractor fuel, etc.) for application i, MC s . The total cost of the spray programme is thus:
where M is the total number of applications in a growing season. The cost due to disease-induced yield loss, C Y (S,A), depends on the severity of the disease when no fungicide is used, S, and the reduction in the severity due to spray programme A, giving:
where P Y is the sale price of the produce (the grain or grape), Y is the yield of the produce given that the crop is disease free, S is the disease severity in the absence of a fungicide treatment programme, and A is the application programme. g(S,A) is the fraction of the maximum yield lost under application programme A when the untreated disease would develop severity S.
The disease severity at the key growth stage is caused by the pathogen population that consists of a strain sensitive to the fungicide and a strain with reduced sensitivity, or complete resistance, to the fungicide. The disease severity caused by the sensitive and the resistant strains under application programme A is given by S S (A) and S R (A), respectively. The total severity is the sum of the severities due to the two strains. How the severity of the disease due to the two pathogen strains depends on the fungicide application programme, A, and this will be discussed later.
The expression for the cost due to disease is thus:
This is the cost function used to calculate the long-term average cost of disease control and the expected cost under risk averseness.
The long-term mean cost of disease control
Before the disease epidemiology and the fungicide treatment programme are explained, equations for the mean cost of disease control are derived. This shows how cost of fungicides and cost due to disease-induced yield loss can be combined with the seasonal difference in disease severity. The expected cost of control, i.e. the long-term average cost, when applying treatment programme A, E(C(A)), is calculated from:
PðSÞCðS; AÞdS
The optimal application programme is defined as the application programme that minimizes the long-term mean cost due to disease.
Box 1. Application programme
The application programme, A, is the series of fungicide applications in the treatment programme, A = {A 1 , A 2 , A 3 , . . .}. Subscript i = 1, 2, 3, . . ., M refers to the spray number where M is the total number of applications during the crop growing season. Each of the applications consists of a spray with a fungicide at dosage D i . A two-applications programme is described here. Other spray programmes can easily be described using the same methods.
After a fungicide application the fungicide affects the pathogen's lifecycle parameters for some time. Because the fungicide is broken down by the plant's metabolism, and sunlight and/or is washed off leaves by rain, the effectiveness of the fungicide decreases over time and finally becomes zero. The time window over which the fungicide affects the pathogen's lifecycle parameters is called 'the fungicide time window'. Time periods where no fungicide is active are termed 'the non-fungicide time window'. So, for a two-spray programme one season is divided in five time windows that alternate non-fungicide and fungicide time windows. In time window 1, from the start of the crop growing season until the moment the first spray is applied, is a non-fungicide window of length D If the decay of the fungicide's activity is so slow that windows D 2 and D 4 overlap, the action of the fungicide can be described throughout one extended window, and window D 3 does not exist.
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The cost of disease control under risk aversion Growers may be willing to pay the additional cost of a higher fungicide total dose each year as a risk-reducing investment (i.e. 'insurance') in order to be protected from occasional large costs. Previous studies about risk aversion and the use of pesticides (Pannell, 1991) account for the risk aversion considerations of growers' objectives to: (i) maximize expected utility; utility is then assumed to be a function of 'initial wealth' plus the monetary gain; or (ii) minimize the maximum cost to disease. The latter is known as the 'maximin' principle. The maximin idea is used as it closely aligns with the idea that a grower aims to reduce the loss they can incur from a severe epidemic. The grower's aim is phrased as: 'A grower aims to minimize the expected costs incurred from the once each N years where a large epidemic develops during the growing season'. From the probability density function, P(S), it can be seen that once each N years the epidemic severity, S, is S ≥ S N , and S N is found from:
The expected costs incurred given that the epidemic develops a severity equal to or larger than S N is calculated from:
CðS; AÞdS where the factor (1⁄N) is to scale P(S) such that for S > S N it is a probability density function. The optimal application programme is then found from:
Dynamics of the disease
Disease dynamics are described here, together with the calculation of the severity that will develop at the key growth stage when no fungicides are applied, S. The effect of the fungicide on the pathogen dynamics, and consequently on disease severity, is then introduced.
The epidemic severity under the fungicide treatment programme
Disease severity caused by the sensitive and the resistant strain, S S (t) and S R (t), respectively, is tracked. The dynamics of the severity caused by these strains is given by:
where r S (t) and r R (t) are the rates of increase in severity of the sensitive and the resistant strain, respectively. These rates are affected by the fungicide applications. The growth rates of the strains depends on fungicide dose, and r S (D) and r R (D) are written for the growth rate of the sensitive and resistant strain, respectively, when the fungicide is present. It is assumed that during time periods when the fungicide is not present (before treatment and after fungicide has decayed to a negligible dose), the growth rates of the two strains have the same value, r.
Considering here the case of a two-spray programme (which can be extended to more applications), and referring to Box 1, at the end of the last time window the severity of the strains is given by: where S S (0) and S R (0) are the severity of the strains at the start of the growing season. The sum of these is the total severity of the primary inoculum, S 0 . The definition of the fraction resistant, h = S R ⁄(S S + S R ), can be rewritten as S S (0) = (1 À h)S 0 and S R (0) = hS 0 . With some further rewriting and reorganizing it is found that:
where S is the severity of the epidemic when no fungicide treatment programme is in place. When the resistant strain is qualitatively resistant to the fungicide S R = hS.
The growth rates r S and r R as a function of fungicide dose
The growth rates of the fungicide-sensitive and fungicide-resistant strains depend on fungicide dose D. A model is used that compartmentalizes host tissue into densities of Healthy, Exposed (latent), Infectious and Removed (post-infectious) categories. This H-E-I-R model describes the dynamics of the epidemic. As discussed in Madden et al. (2007) , the growth rate of the pathogen population in the H-E-I-R model is given by:
and p is the latent period, i is the infectious period and b is the transmission rate of the pathogen. Each strain of the pathogen has its own growth rate, r S and r R , and depends on the fungicide applied. The effect of the fungicide is expressed through its effect on the lifecycle parameters of the pathogen strains. As discussed in Hobbelen et al. (2011a Hobbelen et al. ( ,b, 2013 ) a systemic fungicide affects both the pathogen transmission rate, b, (through the infection efficiency and spore production rate) and the length of the latent period, p.
The transmission rate, b: A dose D of the fungicide results in a transmission rate:
for the sensitive strain and:
for the resistant strain, where b 0 is the maximum transmission rate when no fungicide is used, b mS and b mR are the maximum fractional reduction of the transmission rate (i.e. at infinite dose) of the sensitive and the resistant strain, respectively, under applications of the fungicide. When the resistant strain is qualitatively resistant,
The latent period, p: In the H-E-I-R models, as used by Hobbelen et al. (2011a Hobbelen et al. ( ,b, 2013 , the latent period is given by p = 1⁄c, where c is the probability per time unit that a lesion in the latent stage becomes an infectious lesion. The transmission rate as a function of fungicide dose is given by:
for the resistant strain, where 1⁄c 0 is the latent period when no fungicide is used. It is assumed that the shape parameters, k S and k R , and the maximum reduction parameters, b mS and b mR , have the same values as for the effect of the fungicide on transmission rate. This assumption can easily be changed if observational data are available for the pathosystem being represented.
The yield loss function, g(S,A)
The only remaining quantity to define is the yield loss function, g(S,A), describing the effect of disease severity on the fraction of the yield lost to disease. A range of yield loss functions has been published for different plant pathogens (Madden et al., 2007) . Any relation describing the effect of disease severity on yield loss can be used in these calculations of costs. Here a simple and flexible disease yield relation is used that allows linear, decreasingly steep with disease severity and increasingly steep with disease severity yield loss functions.
gðS; AÞ ¼ lX 1 þ rX X is the severity as it develops under the fungicide application programme,
For r = 0 this function describes a linear disease yield loss relation (Fig. 1a) . For r > 0 the slope of the yield loss relation decreases with increasing disease severity (Fig. 1b) , and for r < 0 the slope of the yield loss curve increases with increasing disease severity (Fig. 1c) . As can be seen from the figure, there will be parameter values l and r for which g(S) > 1 for a value S > S max . In such cases yield is entirely lost and g(S) = 1. Text S1 explains the adjustments to the cost calculation needed in these cases.
Results
Applications: septoria tritici blotch on wheat and powdery mildew on grapevine
The model is applied here to two contrasting cases, septoria tritici blotch (STB) on wheat (Triticum aestivum) and powdery mildew on grape (GPM). STB is caused by the fungal pathogen Z. tritici, and is one of the main global diseases on wheat. GPM is caused by the fungal pathogen Erysiphe necator, which frequently infects ornamental, table and wine grapevines (Vitis vinifera). One of the key differences between these two cases is the disease-yield loss relationship. The main cause of yield loss from STB is due to the pathogen reducing the green leaf area available for photosynthesis and thereby reducing the rate of build-up of grain biomass. Both grain numbers and grain size are reduced. GPM also causes reduced berry numbers and weight, but its main effect is that grapes covered by more than 5-10% mildew are rejected by the wine industry. This results in a gradual increase of yield loss at low disease severity, due to the loss of yield mass, with a sudden very steep increase in marketable yield loss when disease severity exceeds 5-10% (Fig. 1c) . Two groups of fungicides with different modes of action are considered, to which very contrasting levels of resistance develop. The QoI (FRAC C3) fungicides are typical examples of fungicides to which qualitative resistance develops in the plant pathogens under consideration, due predominantly to a single CytB mutation G143A (Bartlett et al., 2002) . In contrast are the triazole group of DMI (FRAC G1) fungicides, to which both pathogens develop quantitative resistance. Resistance to the triazoles is developing through strains harbouring an ever more complex set of Cyp51 target site, Cyp51 gene promoter and efflux pump mutations, associated with decreased DMI sensitivity (Parker et al., 2014) . The system is simplified here by considering two strains, one of which is quantitatively resistant. A summary of all model parameters for both pathosystems is given in Table 1 . The dose-response curves for all four pathogen fungicide combinations are shown in Figure 2 .
The QoI case, qualitative resistance Figure 3(a,b) shows the long-term average cost of disease (fungicide application costs + costs due to yield losses) as a function of dose for a range of frequencies of the resistant strain. Typically, starting from the untreated situation (dose is 0), the mean cost decreases with increasing dose due to the increased control of the pathogen. At higher dosages the dose-response curve approaches an asymptote. This means that each additional increment of increasing dose provides less additional control than at low dosages. The increased cost of the fungicide with increasing dose then causes the mean cost to increase with increasing dose.
The dose that minimizes the mean cost varies with the frequency of the resistant strain. In the case of STB, the optimal dose is smaller in situations where the frequency of the resistant strain is larger. This implies that it is not justified from a cost-benefit perspective to increase fungicide dose when resistance is developing in the pathogen population.
The situation for grape powdery mildew is different. As long as the frequency of the resistant strain is below 0.1, the optimum dose increases when resistance develops in the pathogen population (Fig. 3b) . However, when the frequency of resistance is larger than 0.1, the financially optimum dose decreases with resistance frequency.
The two different trends for the optimum dose when resistance builds up are summarized in Figure 4(a,b) . The optimal dosages are low compared to what growers normally apply, as these calculations do not account for risk-averse treatment decisions.
The reason that the optimal dose first increases and then decreases for GPM becomes clear from Figure 5 . The figure shows the fraction of the years that the yield is totally lost because the disease severity increases above 10%, and the grapes are rejected by the wine industry, despite using full fungicide dose rates at each application. In this case, when applying full dosages of the fungicides, the number of years the yield is rejected for wine making is small for resistance frequencies below 0.1. A higher dose is needed to keep the disease severity below 10% in less than 20% of the years. Above a resistance frequency of 0.1, the number of years where the grapes are rejected becomes large and applying a lower fungicide dose becomes a financially better option.
In the more realistic case of a risk-averse grower, Figure 6(a,b) shows the optimal dose as a function of the frequency of resistance for three levels of risk aversion.
For example, '10% highest epidemics' means that the grower applies the fungicide at doses which protect the crop against the 10% largest epidemics that can develop during a growing season.
It can be seen that in both the STB and the GPM cases, the optimal dosages are much larger for growers that are risk averse. The optimal doses for STB and GPM are up to twice as large as the optimal dose in the long-term mean cost case.
Strikingly, in the GPM case the optimal dose falls abruptly to zero dose above a certain frequency of resistance. This switch point, for all levels of risk aversion, is between a frequency of resistance of 0.2 to Plant Pathology (2018) 67, 549-560 0.35. When the frequency of resistance has increased above the switch point, the grower should no longer apply the fungicide and should instead start applying other control methods including other fungicides. This is because the number of years that the harvest is rejected increases because the resistant strain is abundant enough to develop a severity larger than 10% in most years.
The triazole case, quantitative resistance
Where quantitative resistance to the fungicide develops, the effect of resistance on the optimal application dose is very different. Figure 3(c,d) shows that for both pathosystems, the optimal dose increases with the frequency of resistance in the pathogen population. This difference between the quantitative resistance case and the qualitative resistance case is further shown in Figure 4(c,d) . Even at high levels of resistance it turns out to be financially justified to use a high dose of the triazole fungicide to compensate for the high levels of the resistant strain that is more difficult to control. This is in sharp contrast to the QoI fungicide case for both pathosystems.
In the GPM and QoI case, the optimal dose decreased at higher levels of resistance in the pathogen population because in many years it is impossible to reduce the severity below the critical 10% level when there is resistance. In contrast, for the triazole case the optimal dose increases with increasing frequency of resistance, even for very high frequency, say h > 0.5. The reason can be seen from a combination of Figures 2 and 5. The resistant strain can still be adequately controlled by high fungicide dosages (Fig. 2) . This leads to the situation that even when resistance is at high levels in the pathogen population it is possible in many years to keep the severity below 10% by applying high dosages. Clearly the losses in the occasional year where high fungicide dosages are not able to reduce the severity below 10% and resistance levels are high do not change the trend that increasing frequency of resistance require higher dosages to be used. Figure 6 (c,d) shows that for risk-averse growers, as in the qualitative resistance case, an increased level of risk averseness increases the optimal fungicide dose. In the GPM case optimal dosages increase with increasing frequency of resistance. At no point does the dose drop to zero as in the QoI case. Again this is due to the useful level of control that a full dose of the azole fungicide still provides when resistance frequency is high, because the quantitatively resistant strain can be controlled by high dosages. Figure 5 The fraction of years where all grape yield is lost because the severity on the grape bunches increases above 10%, when the full dose of the fungicide is applied.
Optimal dose
Generalizations
This section explores the extent to which the results can be generalized from the case studies, by a very wide parameter exploration. Only some results that answer key questions about generalizations are shown; all results are available on request.
When qualitative resistance to the fungicide develops, there are cases where the optimal dose increases, and there are cases where the optimal dose decreases, with increasing frequency of resistance. What determines whether the optimal dose increases or decreases with the frequency of resistance? It has been found that for all linear and for all decreasingly steep disease-yield loss relations, the optimum dose decreases with increasing fraction of resistance in the pathogen population. This holds both for the long-term mean cost and for the case of risk-averse growers. This conclusion holds for biologically plausible changes in any of the parameters in the model.
Only when the disease-yield loss relation becomes steeper are there some cases where the optimum dose increases with increasing frequency of resistance. There are two quantities that determine whether an increasing fraction of resistance increases the optimal fungicide dose. The first is the combination of the steepness of the disease-yield relationship and the untreated severity probability density function, P(S). The determining quantity is the fraction of years in which the untreated disease severity is larger than the severity at which all marketable yield is lost. The larger this fraction, the more likely it is that the optimum dose increases with increasing frequency of the resistance in the pathogen population. The second determining parameter is the level of risk aversion of the grower. The more risk averse a grower, the more likely it is that the optimum dose increases with increasing frequency of resistance in the pathogen population. Note however again that the disease-yield loss relation needs to be very steep. There are no cases where a linear or a decreasingly steep diseaseyield loss relation leads to the optimal dose increasing when resistance develops.
For the linear severity-yield loss relation, such as for the Z. tritici case, the optimal dose decreases with the frequency of resistance in the pathogen population when qualitative resistance develops, such as in the QoI case, and increases for the triazole case where partial resistance develops. The key question thus is what level of resistance causes the optimal dose to increase or decrease with the frequency of resistance? There are two ways quantitative resistance can be expressed in the dose-response curve. Firstly, the shape parameter k, determining the curvature of the dose-response curve, is zero for qualitative resistance and larger than zero for quantitative resistance. Secondly, the asymptote, b, determining the maximum effect of the fungicide on the lifecycle parameter (and hence the position of the dose-response asymptote), is zero for qualitative resistance and larger than zero for quantitative resistance. Figure 7a shows the effect of the curvature parameter on the optimal dose versus frequency of resistance relationship. When k is 0.5 or approaches the same value of the susceptible strain, there is no difference between the susceptible and the resistant strain, resulting in a similar dose being optimal irrespective of the frequency of resistance. Figure 7b shows the effect of quantitative resistance expressed through the asymptote. Again for values of b very close to zero (qualitative resistance), the optimal dose decreases with the frequency or resistance. However, a small change to b > 0.1, reverses the trend and the optimal dose increases with the frequency of resistance. These graphs are made for the triazole cases. For the QoI cases the trends are qualitatively the same. The optimal dose per application as a function of the frequency of resistance for three levels of risk aversion. The '50% largest epidemics' means that a grower aims to protect their crop for the epidemics in the 50% of the growing seasons that the highest epidemics develop; '10% highest epidemics' means that the grower protects their crops against the 10% largest epidemics that can develop during a growing season.
This pattern is maintained when risk aversion is included (data not shown). Quantitative resistance causes the optimal dose to increase with the frequency of resistance in the pathogen population, and the effect of the curvature parameter is much larger than that of the asymptote.
A range of other parameters have been tried in the model, but the qualitative trends as described here do not change, although there are of course quantitative differences. Surprisingly the cost of the fungicide has no effect on the qualitative patterns described. Note that for a more costly fungicide the optimal dosages are lower, but none of the directions of the trends are changed.
Discussion
The present study has shown how to quantify the optimal dose when fungicide resistance is developing in the pathogen population. The model and analytical method are quite general and can be applied to a wide variety of pathosystems and fungicides. The numerical scenarios studied cover two contrasting pathosystems and two contrasting fungicides. An exploratory parameter analysis has also been done to be able to generalize the findings. When qualitative resistance develops against the fungicide, there are two possible outcomes:
1 when the disease-yield loss relation is linear or decreasingly steep, the optimal fungicide application dose decreases with increasing frequency of resistance in the pathogen population. 2 when the disease-yield loss relation is increasingly steep there are cases where the optimal fungicide treatment dose increases with the frequency of resistance and there are cases where the optimal dose decreases with frequency of resistance.
The parameter exploration showed that these general conclusions are not dependent on the value of other parameters in the model, though differences in the values exist. When quantitative resistance develops against the fungicide, the optimal dose increases with increasing frequency of resistance in the pathogen population. This conclusion is not sensitive to any of the model parameters except for the parameters of the dose-response curves. The dose-response curve (parameters) and the diseaseyield loss relationship are the key determinants of whether the optimal dose increases or decreases with increasing frequency of resistance in the pathogen population. Only when the parameters of the dose-response curve are such that the resistant strain is close to fully resistant, the optimum dose decreases with increasing frequency of resistance. The shape of the disease-yield loss relationship then determines whether the optimal dose increases or decreases with increasing frequency of resistance. For all other cases where the resistant strain is not (close to) qualitatively resistant to the fungicide the optimal dose increases with increasing frequency of resistance.
The adjustments of application programmes as summarized above would require growers to be aware of changes in pathogen sensitivity or fungicide dose-response curves. Where such information is available from pathogen monitoring and field experiments, it is usually communicated between growing seasons. This enables adjustment to quantitative resistance that occurs over several seasons, but more immediate feedback (for example, from immediate genotyping of pathogens from field samples using LAMP assays) would be required to enable within-season adjustment to qualitative resistance.
This study analysed cases where a sensitive strain and a resistant one (whether quantitatively or qualitatively resistant) are simultaneously present in the pathogen Plant Pathology (2018) 67, 549-560 population. A further question is whether the dose should be increased or decreased in scenarios with more than two strains, e.g. in a situation where a sensitive, a quantitatively resistant and a qualitatively resistant strain are present in the pathogen population, as is the case currently in Z. tritici and SDHI fungicides. In such cases it will depend on the frequencies of the various strains whether to increase or decrease dose. The strain frequencies in their turn are determined by the emergence and selection history of the pathogen population. Using the theory developed by Crow & Kimura (1970) , combined with an epidemiological model incorporating all the different strains, it should be possible, though complex, to model that situation.
To the best of the authors' knowledge, there are no published experimental studies into the financially optimal fungicide dose when resistance is developing. There is only one published modelling study that considers the optimal application dose when resistance is building up in the pathogen population (Hobbelen et al., 2011b) . In that study, STB was controlled by mixtures of a fungicide with a high risk of resistance developing and a fungicide with a low risk of resistance developing. They found that the optimal dose increased with increasing frequency of resistance in the pathogen population. At first sight this seems to contradict the findings here. However, Hobbelen et al. (2011b) defined a fungicide application programme as providing effective control when the pathogen reduces the healthy area duration integrated over the top three leaves (HAD) by maximally 5%. In all other cases the control is assumed not effective enough to warrant fungicide applications. Translating this to the disease-yield loss relation, they model a zero loss as long as the reduction in HAD is less than 5% and 1 (full loss) when it is larger than 5%. This constitutes an extreme case of increasingly steep diseaseyield relationship, and is expected thus to give increasing optimal dosages when the resistance frequency increases. The results of Hobbelen et al. (2011b) are thus in line with the present findings.
As mentioned in the introduction, the pesticide usage survey data from the UK (https://secure.fera.defra.gov. uk/pusstats/) show that QoI usage against STB on wheat fell sharply after resistance became widespread. Resistance to the QoI fungicides is now at a frequency close to 100% in STB. Growers responded to increasing resistance by applying lower doses, in agreement with the present findings. The trend for the triazole fungicides is different. The pesticide usage statistics show that with increased resistance in septoria blotch, growers have gradually increased the number of applications and total dose (https://secure.fe ra.defra.gov.uk/pusstats/). Resistance to triazole fungicides in Z. tritici is made up of a sequence of strains showing increasing resistance to the triazoles. The modelling suggests that the financially rational disease control dose should be increased when resistance develops and is thus in agreement with what has happened in practice.
The findings thus agree with what may already seem intuitively correct to many. However, a formal analysis of decisions that seem intuitively clear is still of key importance. This has been shown previously on topics like the dose rate debate. For many researchers and policy makers it seemed intuitively correct for decades that fungicides should only be used at the maximum permitted dose to prevent or delay resistance from developing. It has been shown that this intuition was not underpinned by evidence (van den Bosch et al., 2011) , and in almost all cases studied, an increasing dose increases the selection for fungicide resistance.
The present study has shown circumstances in which the fungicide dose that gives the optimal financial return over one growing season increases or decreases with increasing levels of resistance. Previous work has clearly shown that an increased fungicide dose (either by increased number of applications or higher dose per application) is likely to increase the selection for resistance (van den Bosch et al., 2011 Bosch et al., , 2014a . Increasing the dose of the applications will thus increase the financial gain within a growing season, but will also cause the fungicide to develop resistance faster and the pathogen to become increasingly difficult to control. The model thus shows, for some types of fungicide resistance, that there will be a direct conflict between what growers must do to optimize their within-year economic gain and what might be best in the longer term for resistance management and economic optimization of fungicide use. For other fungicides, to which qualitative resistance develops, the short-term optimal gain and the longer-term resistance management goals go in parallel. The potential for conflict between short-and long-term optimization presents a challenge in developing policy and advice to industry. The methods developed here can be extended to analyse long-term gain versus short-term gain.
